| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |